EPO Patents = 2

Forward Citations = 6

Loading Chart...

5 inventors (with patents filed for the assignee):

Greg Bryden Sebring (2 out of 3 patents)

Danny H Lewis (2 out of 30 patents)

Kenneth Hinds (2 out of 3 patents)

4. Kathleen M Campbell (2 out of 3 patents)

5. Paul J Schmidt (2 out of 78 patents)

4 patents: Sort by Forward Citations

1. 9789196 - Site-specific insulin-polymer conjugates (2017-10-17),

2. 9532953 - Solvent extraction from biodegradable microparticles (2017-01-03),

3. 9439864 - Solvent extraction from biodegradable microparticles (2016-09-13),

4. 9040664 - Materials and methods for preparing protein-polymer conjugates (2015-05-26),

Antriabio, Inc. is a biotechnology company focused on developing innovative therapies for the treatment of cancer and autoimmune diseases. The company's pipeline includes novel small molecule drugs with strong potential to address unmet medical needs. Antriabio's mission is to improve patient outcomes and quality of life through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#223 in Denver, CO

#1,363 in Colorado

#58,999 in US

Denver, CO, United States of America

Antriabio, Inc.